Transgene S.A. buy metanicnor
Start price
31.05.14
/
50%
€9.91
Target price
18.05.15
€14.00
Performance (%)
-50.20%
End price
18.05.15
€4.94
Summary
This prediction ended on 18.05.15 with a price of €4.94. The BUY prediction by metanicnor for Transgene S.A. performed very badly with a performance of -50.20%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Transgene S.A. | -0.915% | -0.915% | 29.641% | -56.700% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by metanicnor for this prediction
In the thread Transgene S.A. diskutieren
TG4010
Vielversprechende Ergebnisse einer Studie über TG4010
bald in Phase-III-sein?
Transgen suche einen Finanzpartner
Termin im September 2014 detaillierte Ergebnisse auf TG4010
(Laufzeit überschritten)